Prestige Consumer Healthcare (NYSE:PBH) Research Coverage Started at Canaccord Genuity Group

Canaccord Genuity Group initiated coverage on shares of Prestige Consumer Healthcare (NYSE:PBHGet Rating) in a report issued on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $71.00 target price on the stock.

PBH has been the subject of several other reports. DA Davidson reissued a neutral rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. Oppenheimer dropped their price objective on Prestige Consumer Healthcare to $63.00 in a report on Thursday, September 29th. Canaccord Genuity Group began coverage on Prestige Consumer Healthcare in a report on Wednesday, November 16th. They set a buy rating and a $71.00 price objective for the company. Finally, StockNews.com initiated coverage on Prestige Consumer Healthcare in a report on Wednesday, October 12th. They set a buy rating for the company. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus price target of $68.75.

Prestige Consumer Healthcare Stock Up 2.2 %

Shares of NYSE:PBH opened at $59.75 on Thursday. Prestige Consumer Healthcare has a 52 week low of $48.51 and a 52 week high of $63.47. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.29 and a current ratio of 2.21. The company’s fifty day moving average is $53.02 and its 200-day moving average is $55.19. The company has a market capitalization of $2.96 billion, a PE ratio of 14.50, a P/E/G ratio of 1.78 and a beta of 0.55.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Meeder Asset Management Inc. grew its position in shares of Prestige Consumer Healthcare by 79.0% in the 2nd quarter. Meeder Asset Management Inc. now owns 451 shares of the company’s stock valued at $27,000 after purchasing an additional 199 shares during the period. Global Retirement Partners LLC boosted its position in Prestige Consumer Healthcare by 3,435.7% during the 3rd quarter. Global Retirement Partners LLC now owns 495 shares of the company’s stock worth $27,000 after acquiring an additional 481 shares during the last quarter. Lindbrook Capital LLC boosted its position in Prestige Consumer Healthcare by 3,000.0% during the 2nd quarter. Lindbrook Capital LLC now owns 496 shares of the company’s stock worth $29,000 after acquiring an additional 480 shares during the last quarter. Ronald Blue Trust Inc. boosted its position in Prestige Consumer Healthcare by 349.3% during the 3rd quarter. Ronald Blue Trust Inc. now owns 602 shares of the company’s stock worth $36,000 after acquiring an additional 468 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its position in Prestige Consumer Healthcare by 474.7% during the 3rd quarter. Quadrant Capital Group LLC now owns 1,092 shares of the company’s stock worth $54,000 after acquiring an additional 902 shares during the last quarter. 99.37% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Company Profile

(Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Recommended Stories

Analyst Recommendations for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.